← prelander teardowns

Top 5 Astaxanthin Liver Supplements of 2026 – Clarity MD

claritymd.co · family top5 · open the live page ↗ · kept on the prelander swipe · found on the store (not yet seen behind an ad)
ArchitectureF4 — Auto tag F4, confirmed: five ranked cards under a scoring frame. One first-person narrator (the same named reviewer as the sibling page) where the house F4 has none. Her first person appears in the deck and at the end of the problem block only; one rival's bottom line switches to an editorial plural (entry 29). No scene, no story. Narratorthe same named woman reviewer, no title or credential, who says she compared five formulas (editor, 1) Big ideaOne focused antioxidant taken every day protects an overworked liver better than a multi-herb cleanse. Hook devicecategory title plus a question VillainThe short-term detox and the multi-herb blend with hidden amounts; behind them, the oxidative strain of modern food, alcohol and medicines. What they call itNone named. The working idea is targeted protection of liver cells against oxidative stress from one 12 mg active. Proof stackthe reviewer's own comparison: asserted, never shown · oxidative stress described as studied in connection with four liver changes: no study named · third-party testing and a cGMP facility in the US: stated, no report shown · a 90-day guarantee · rivals' studies and certifications, reported with attribution to each maker · letter grades A+ to B-: no method; fine print credits a ranking system the page never describes · no customer survey, no customer count, no rating, no doctor OfferNo price anywhere on the page. One softgel a day, a 90-day money-back guarantee, subscription savings mentioned without a figure, sold only on the brand's own site. Reader enters / leavessolution-aware → product-aware Product first named21% down the page · 3 buttons, the first at 36%

The two chiefs

House chief · 5/10

Top-5 ranking advertorial on the seller's own store, dressed as a review site · solution shoppers from search and retargeting (found on the store's page list, not yet seen behind an ad) · adults worried about fatty-liver risk or raised enzymes, or who feel tired, bloated or foggy · solution-aware in, product-aware out (no price) · no named mechanism: targeted antioxidant protection of liver cells from one 12 mg active

Lead: Problem lead: the overworked organ, then the reader's symptoms. Grade B- for order and C for delivery, since it arrives as one block of 177 words.
Offer: No price. A 90-day guarantee, subscription savings with no figure, official site only. Grade D+: the reader cannot weigh value.
Close: A recap sentence, eight ticks, a benefit section, a reason summary and three links. Risk reversal is the only closing force. Grade C.
Throughline: Concern for a tired organ, then spec sheets, then the concern again near the end. Flat through the middle half.

Strongest

  • entry 7: symptoms that reach readers without a lab result
  • entries 14 and 15: the product positioned as one active against blends
  • entries 19 to 23: a generously graded runner-up with a plain ranking reason
  • entry 46: the opening image brought back at the close

Weakest

  • entries 40 to 42: leftovers from another ranking
  • entries 8 to 11: criteria nobody can apply
  • entry 13: no price
  • entries 24, 30, 36: borrowed fine print
  • entry 37: grades so close together that the ranking decides nothing

Craft chief · REVISE

It sounds like a careful committee: every sentence is safe, most of them are lists, and the last card talks about a product that is not on the page.

Strongest

  • entry 7: the internal order of the problem block, from the organ's load to the standard
  • entry 14: a con that positions the product as one focused active
  • entry 23: the ranking reason stated in one plain sentence
  • entry 46: the return to the opening image before the last link
  • entry 6: a lineup hero that names no brand

Weakest

  • entries 40 and 42: cons and a bottom line written for a different product and brand
  • entry 38: a drawback filed under pros
  • entries 24, 30, 36: fine print that credits a ranking system the page never describes
  • entries 8 to 11: three bare titles, then ten scoring factors
  • entry 13: value claimed with no price on the page

001 REVISE · entries 3, 7, 11, 15, 16, 47: sentence after sentence built on lists of three to ten abstract nouns at the same length. Cost: attention, the ear stops following by the second list · 002 PASS·noted · jobs present: attention 2 to 3, belief 7 to 11, desire 12 to 16, action 18, 48, 50. Desire is thin with no price and no proof block · 003 PASS·noted · mostly plain; several abstract compounds in entries 15 and 16 are not words a shopper uses · 004 REVISE · entries 38 to 42: a drawback filed under pros, four cons about a different product and a bottom line about a different brand. Cost: trust, at the point where the most careful readers are still reading · 005 PASS·noted · the headline's question is answered by the ranking; the deck's claim of a personal comparison (entry 3) is never shown · 006 REVISE · value is claimed twice with no price (entries 13, 39); benefits are abstract verbs and nouns (entries 15, 16, 47); the criteria carry no number (entries 8 to 10). Cost: belief, the reader has nothing to point at · 007 N/A · the extracted rows carry no emphasis data for this page · 008 PASS·noted · hedging verbs stack on the winner's card (entries 15, 16), where they drain desire; on rival cards the same caution reads as fairness · 009 N/A · a ranking, not a story lead · 010 REVISE · reads written, not said, in entries 7, 15, 16 and 49. Cost: the reviewer stops sounding like a person, which a first-person ranking depends on · 011 PASS · the hero's alt text states the image's job (entry 6); no claim is trapped in an image as far as the rows show · 012 REVISE · fine print under three rival cards credits a scoring system that is not this page's (entries 24, 30, 36); the reading time contradicts the sibling page's (entry 4); the footer is bare (entry 51). Cost: trust · 013 PASS · entry 7 names how the reader feels in ordinary words · 014 PASS·noted · the overworked organ of entries 3 and 7 returns in entry 46; between them the page is spec sheets · 015 REVISE (tier 1, flagged not rewritten) · six long dashes (entries 7, 13, 15, 49); one contrast construction used five times (entries 14, 16, 29, 38, 39); stacked parallel lists throughout · 016 PASS · no house names; the ingredient is introduced with its job inside the winner's card (entry 15) · 017 PASS·noted · entry 2 is a label plus a question; emotion and stakes come only from the deck (entry 3). Defensible for a shopper who typed the category, weak for cold traffic · 018 REVISE · one idea with color: a single focused active against multi-herb cleanses (entries 14, 15). Everything else would survive a competitor swap. Instruction: build the page around that contrast · 019 N/A · no founder voice · 020 REVISE · leftovers from the store's astaxanthin ranking sit inside entries 40 and 42; the card template, link labels, one disclaimer and the footer are shared with the sibling page. Cost: it reads as a template, and at entry 40 as an error · 021 N/A · a page, not a sequence · 022 PASS · nothing flagged for boldness; the page's fault is the opposite, it is over-hedged · 023 PASS·noted · the first screen names a ranking of five; the deck spends its second half on a list of abstractions · 024 PASS · the verbs match a supplement's role throughout · 025 PASS·noted · for the guard: the reading time (entry 4), the 4 mg and 30-softgel figures that belong to another product (entries 40, 42), the missing grade on card four (entry 31)

Take

  • When there is no tester to qualify, qualify the reader: put the problem before the criteria, and keep this internal order (the organ at work, the modern load, how it feels, see your clinician, a quick fix falls short, so here is the standard) (entry 7).
  • Mirror everyday signs as well as lab results, so the page reaches readers who have no diagnosis (entries 7, 11, 16).
  • A hero that shows five products and names none holds the comparison frame for the whole first screen (entry 6).
  • Admit a limit that is really the position: one focused thing, not a blend (entry 14).
  • Report each rival's claims with attribution to the rival, so the reviewer vouches for nothing (entries 20, 26, 34).
  • One sentence per rival that says why it ranks where it does (entries 23, 29, 35).
  • Bring the opening image back in the last section before the link (entry 46).
  • Price a low-dose rival at the full dose, not per bottle: the leftover paragraph shows the store's own move on its astaxanthin ranking (entry 42).
  • End the recap on the villain, so the final contrast is fresh at the last link (entry 49).

Leave

  • Every liver, fatty-liver, enzyme and detox claim: CellScience holds none. The nearest gate claims are kidney numbers, brain fog, energy, bloating, eyes and joints.
  • A product retitled for an organ (entry 12).
  • Criteria as bare titles with no number, and a ten-factor scoring list (entries 8 to 11).
  • Value claimed with no price anywhere on the page (entries 13, 39).
  • Guarantee length as a ranking reason: ours is 30 days (entries 21, 27, 29, 33, 35).
  • Letter grades with no method, and a grade range so flat that the ranking decides nothing (entries 12, 19, 37).
  • Template leftovers: cons and a bottom line from another card, a drawback filed as a pro, fine print that credits another publisher's scoring (entries 24, 30, 36, 38, 40, 42).
  • The 177-word block, the five-item lists, the long dashes and the stacked hedges (entries 7, 15, 16).
  • A reading time that contradicts the sibling page's, and a reviewer who cannot be verified (entry 4).
  • Their sentences. Nothing on this page is to be reused as wording.

Line by line · 51 entries

Every line is described in our words; the page's own text stays on the page (open it beside this table). Shaded rows carry the most pull.

#BeatWhat the line doesLever · readerWhy hereCraftOn our page
1
0.2%
disclosure
cta · 2 w
The same two-word advertising label as on the store's other ranking pages, placed above the headline as a link.candor
solution-aware
First on the page, where it is read before the reader has a stake in anything. It lets the ranking speak in a reviewer's voice without a later admission.Identical on every ranking page of the store: a template element, not a written line.page-furniture
CS-P1 has its ad disclosure in the footer only. A short line under the masthead is the low-cost fix. CS-P1 lacks it at the top.
2
0.8%
hook-headline
h1 · 14 w
A category title with the year, then a question asking which of the formulas truly help the liver get healthier.curiosity-gapspecificity
solution-aware
As the first line it has to confirm the searcher is in the right place. It assumes the reader already believes a supplement can help and doubts which one. A ranking is the only possible answer to the question it asks.Fourteen words, the first seven a label. No person, no count beyond the five, no stake. Any liver list on any site could carry it; the sibling page's first-person count is the sharper hook.rewrite-claim
No liver. CS-P1's H1 is the same type, a category ranking, and names four organs the gate holds: kidneys, brain, eyes, joints. Already has. The lesson is what not to settle for: a label headline with no tester and no test.
r10r6b3b4
3
2.3%
deck
p · 41 w
The deck opens on the organ's nonstop workload with a five-item list of what it processes, then says the reviewer compared five formulas on five kinds of support, from cell protection to long-term function.reason-whyearned-authorityfear-of-decline
solution-aware
Under a flat headline the deck has to supply the feeling: an organ that never rests. It prepares the long problem block, which makes the same point at length.Forty-one words holding two five-item lists. The first list is concrete; the second is abstract and blurs. The first-person claim of having compared the products is never shown.rewrite-claim
No liver. Our version raises the stakes of the cell, not of an organ we hold no claim on: ordinary antioxidants guard only part of it. CS-P1's subhead counts softgels and tests and raises no stakes. One concrete list at most for our reader.
p3r1
4
4.5%
authority-stamp
2× p · 12 w
The same reviewer's name with no credentials, an update stamp eleven days earlier than the sibling page's, and a reading time of nine minutes.earned-authorityspecificity
solution-aware
Under the deck, before any content: the claim of a personal comparison needs a name at once, and the year in the title needs a recent date.The reading time cannot be squared with the sibling page's: this page has about 1,560 words and claims nine minutes, the longer sibling claims four. At least one stamp is decoration, not measurement (an unverifiable reviewer; treat as a persona).keep-structure
CS-P1 has a fuller byline: role, years, headshot, date, read time. Already has. Keep the read time true to the word count.
5
5.3%
page-furniture
3× p · 8 w
Three jump tabs: benefits for the liver, a buyer's checklist, and the ranked list.ease
solution-aware
Below the byline, above the hero image. It tells the reader a buying guide is coming before the ranking.The middle tab names the rubric section in a shopper's own words, which is friendlier than the sibling page's clinical label.page-furniture
CS-P1 has no jump tabs. Optional for our reader, with large tap targets.
6
5.8%
image
img
The hero image, whose alt text describes a lineup of five liver products being compared.consensus
solution-aware
Above the first section, so the first screen says five products and names no brand. The winner stays unnamed until its card.The alt text states the job of the image. A lineup keeps the neutral pose that a single product shot would break.keep-structure
CS-P1's hero is our bag alone, captioned as the top pick. A five-product lineup is the alternative to test: it holds the comparison frame for one more screen. CS-P1 lacks it.
7
7.6%
symptom-mirror
h3 · p · 186 w
A heading hints the organ is under more strain than the reader thinks. One long block follows: daily load, modern strain, how trouble shows (tiredness, bloating, fog, a raised enzyme result), then the wish for daily support over a detox.mirroringidentificationfear-of-declinereason-why
problem-aware
It comes before any criteria, unlike the sibling page, which puts method first. With no tester to qualify, the page qualifies the reader. The block ends by naming the standard, so the symptoms become the reason for the rubric.One block of 177 words: a wall on a phone. Inside it the order is sound (organ, load, symptoms, clinician, detox falls short, the standard). Long dashes and lists of three to five items in nearly every sentence give it a generated cadence.rewrite-claim
No liver, no detox. The signs the gate holds for our reader: afternoon energy, brain fog, bloating, tired eyes, stiff joints, kidney numbers. CS-P1's intro talks about vitamins, not about how the reader feels. It lacks a symptom mirror. Ours goes in short paragraphs. Eyes stay benefit-forward.
r7r6r8b3p5r10
8
14.0%
ranking-criteria
h2 · h3 · h4 · 13 w
A heading promises the three things that count most. The first is a title only: focused protection from oxidative stress.specificityopen-loopcommitment
solution-aware
Straight after the block that blamed oxidative strain, so the first criterion is the answer to the problem just described. The reader has to accept that strain is the cause.Five words with no explanation in the extracted rows (the panels are collapsed). One adjective of focus will later separate a single active from a herb blend.rewrite-claim
Our first test is a number: the full 12 mg in one softgel. A benefit-word criterion cannot be checked on a label. CS-P1 already does this better. If protection is named, it is The Cell Shield across the whole membrane.
b7m2
9
15.5%
ranking-criteria
h3 · cta · 7 w
The second factor, again a title only: a daily amount that is both stated openly and large enough to matter.specificitycontrast
solution-aware
Second because it turns the first into something checkable: protection, then how much. It prepares the line about hidden amounts on the winner's card and the hard-to-verify lines on the rivals'.No number. The sibling page says 12 mg at this point; this one uses an adjective the reader cannot apply.keep-structure
Ours has the number and the gate holds it: 12 mg clinical strength against 4 to 6 mg products. CS-P1 already has it as its first axis.
b7
10
16.1%
ranking-criteria
h3 · cta · 6 w
The third factor bundles three things into one title: how well the product is taken up, how well it is made, and whether a person can keep taking it.easespecificity
solution-aware
Last, as the catch-all. It lets the ranking later reward a once-a-day softgel and a long guarantee under the heading of staying the course.Three criteria hiding in one, none defined. The rubric is looser than the sibling page's and gives the grades more room.rewrite-claim
Absorption superiority is not in our gate. Routine is: one softgel a day with a meal that has some fat. CS-P1's fifth method item asks whether you will still be taking it on day 30, the same idea as a question. Already has.
b9r31c3
11
16.9%
ranking-criteria
h2 · p · 72 w
The list heading repeats the title as a new question about defending an overworked organ. The intro names who the five are for (six worries, from fatty-liver risk to fog) and lists ten things each was judged on.identificationreason-why
solution-aware
Just before card one. The list of worries tells the reader the cards were chosen for them. The ten factors replace the three just given, so any order can be justified.Fifty-eight words holding a six-item list and a ten-item list. Nobody can hold ten criteria; the effect is noise that sounds thorough (scoring with no method).keep-structure
CS-P1 names five deciding items and scores three. Keep the short list. Our reader is in their 60s and 70s: three tests they can repeat to a spouse beat ten they cannot. No liver worries on our list.
12
20.7%
ranked-entry
h2 · h3 · 2× p · 11 w
Card one: the store's astaxanthin softgel, here given a product name with the organ in it, its maker, and the top grade. No chips and no summary line.specificityconsensus
product-aware
At about 21% of the page, earlier than on the sibling page, because no proof block stands in front of it. This is the first time brand and ingredient are named. The reader has only the problem block and three titles behind them.Adding the organ to the product name makes a general antioxidant look purpose-built. The grade has no scale beside it (score with no method).rewrite-claim
We never retitle the product for an organ we hold no claim on. Ours is CellScience Astaxanthin 12mg, The Cell Shield, ranked for kidneys, brain, eyes and joints. CS-P1 has the card, with numeric bars. Already has.
b7r10r6b3b4
13
23.1%
ranked-entry
h2 · 9× p · 66 w
Nine pros without labels: the 12 mg dose, the natural Hawaiian source, the oil softgel, outside testing, no hidden blend, US manufacture, the 90-day guarantee, one softgel a day, and value through subscription savings.specificityrisk-reversaleasecontrast
product-aware
Pros first, as on every card. Two of the nine (no hidden blend, one softgel) are there to be set against the rivals below.Flatter than the sibling page: no labels, no customer count, no rating, no doctor, no dollar figure. Value with no price is a claim the reader cannot check.keep-structure
CS-P1's five pros carry more fact per line than these nine. Keep ours: the full 12 mg, lab tested every batch, natural microalgae, one softgel with a meal, the 30-Day Money-Back Guarantee. The ranking's offer is a one-time purchase, so no subscription line. No liver.
b7c3c4c5b9
14
27.5%
ranked-entry
h2 · 2× p · 17 w
Two cons: it is one focused ingredient, not a broad herbal cleanse, and it is sold only on the brand's site.candorcontrastexclusivity
product-aware
The first con names the exact difference from all four rivals before the reader meets them. It frames the rest of the list as one active against four blends.The first con is the most useful line on the card: it positions. It is more honest than the sibling page's sell-out line.keep-structure
CS-P1's 'worth knowing' list opens on a true limit: a supplement, not a treatment. A positioning con for us: it is one ingredient, so it replaces nothing in your routine. The gate holds that. Official site only is also ours.
b9r29
15
29.2%
mechanism
h3 · p · 63 w
The verdict sets a targeted product against the usual multi-herb detox, says the 12 mg dose is meant to shield the liver's cells from oxidative strain, and ties that strain to four changes studied there. It closes on disclosure.new-mechanismcontrastborrowed-authority
product-aware
It is the only place the page connects the ingredient to the organ, so it sits in the winner's card, where the reader asks why this one. It relies on the problem block having blamed oxidative strain.Carefully hedged throughout: the product is built to help, the stress is only linked by study. The four-item list is textbook language. Safe and lifeless, and no study is named.swap-mechanism
The Cell Shield goes here: the molecule spans the whole cell membrane, the part vitamin C and E do not reach, at about 6,000 times the power of vitamin C. No liver pathway. CS-P1 explains fat-solubility and does not say in one sentence what The Cell Shield is. It lacks that sentence.
m2m3p3r5
16
32.2%
ranked-entry
h3 · p · 52 w
The bottom line lists who it is for (five worries), sets focused antioxidant support against a short cleanse, and lists four things it is meant to support as a once-daily habit.identificationcontrastease
product-aware
It closes the card by repeating the problem block's symptoms, so the card ends where the reader started. The cleanse contrast prepares the rivals, several of which are sold as detox products.Two sentences, two long lists. The ear loses the thread by the third item of each.rewrite-claim
No liver. Our list of worries comes from the gate: kidney numbers, brain fog, tired eyes, stiff joints, afternoon energy. CS-P1's card says it is studied for the kidneys, the brain, the eyes and the joints. Already has; keep it to one short list.
r10r6b3p5r7
17
34.7%
disclosure
fine · 25 w
Small print under the card: the results described are users' own accounts and not typical, with a pointer to the product's site.none
product-aware
Under the last persuasive line of the card and above the link.Word for word the line used on the sibling page: shared furniture.page-furniture
CS-P1 has the supplement disclaimer in the footer and nothing under the cards. A one-line note under our card is cheap cover.
18
35.7%
cta
p · 5 w
The first link out, at 36% of the page: a soft text link offering more information about the winner.commitmenteasecuriosity-gap
product-aware
Directly under the winner's card, eight points earlier than on the sibling page because nothing precedes the list but the problem block. No price has been shown, so the link also carries the unanswered question of cost.Same five words as on the sibling page. With no price on the page, curiosity about the cost does part of the link's work.keep-structure
CS-P1 has a full block here with the per-bag price and the guarantee. We show the price; a reader in their 60s or 70s should not have to click to learn it. Keep ours.
19
37.0%
ranked-entry
2× h2 · 2× p · 10 w
Card two: a liquid liver formula from the brand Dose, graded A-, one step below the winner. No chips, no summary sentence.candorconsensus
product-aware
Second place is graded almost as high as first, so the list looks generous. With no summary line, the markdown has to wait for the cons.The gap between first and second is the smallest a letter scale allows, which weakens the case for the winner: if second is nearly as good, why not buy it.keep-structure
CS-P1's numeric bars show where a rival loses (for example 9.5, 3.0, 8.5), which a single letter cannot. Keep ours.
20
38.7%
ranked-entry
h2 · 5× p · 36 w
Five pros: a liquid formula with a clinical study the brand cites, four familiar botanicals, a curcumin sold as better absorbed, a measured serving, and a focus on enzymes and digestion.candorborrowed-authority
product-aware
Praise first. Words of attribution let the reviewer stay uncommitted to what the rival says about itself.Each claim is reported, not endorsed. It reads cautious and a little cold.keep-structure
Attribution is a good habit for our rival cards, and CS-P1 already words Rovina's testing as something the brand says. Already has.
21
41.5%
ranked-entry
h2 · 4× p · 42 w
Four cons: a liquid must be measured and stored, a blend makes it hard to tell which ingredient does what, no money-back guarantee was clearly shown on the page reviewed, and its monthly cost is above a capsule's.contrastloss-aversionease
product-aware
Each con is the mirror of one of the winner's pros (softgel, one active, 90 days, value). The reader has the winner's list fresh from the card above.The guarantee con is worded with care, limited to the page the reviewer saw. No prices are given for the cost claim.rewrite-claim
Skip guarantee comparisons: ours is 30 days. Our markdowns stay on softgels per day to reach 12 mg, a lab result you can see, and cost per day worked from the rival's own price, as CS-P1 does.
b7c3b9
22
44.2%
ranked-entry
h3 · p · 36 w
The verdict names the four botanicals and the liquid format, notes that the brand points to a randomised, blinded, placebo-controlled study, and ranks it among the more believable herbal choices on the list.candorborrowed-authority
product-aware
The rival's study is granted in full, where the sibling page takes a rival's study apart. This page never argues with evidence; it argues with convenience.Three short sentences in a neutral register. Fair, and it leaves the reader with a good reason to buy the rival.keep-structure
Granting a rival's study is honest. If we grant one, our own card must show ours: 60+ clinical studies and the human trial results. CS-P1's cards name no rival studies.
r14b1b3
23
46.0%
ranked-entry
h3 · p · 37 w
The bottom line recommends it to people who want a drinkable herbal product, and gives the reason it ranks second: the winner's one-softgel habit, its longer return window and its simpler recipe make it easier to judge and keep up.contrasteasecandor
product-aware
The only place on the card where the winner is named. It answers the question the high grade raises: if it is this good, why second.The reason given is convenience, not effect. Honest and weak.keep-structure
Our ranking reasons are stronger because they are checkable: softgels per day, lab proof, cost per day. CS-P1 already gives them as scores.
b9c3
24
48.0%
disclosure
fine · 22 w
Small print credits the card's results to a named ranking system that the page never describes and that, to our knowledge, belongs to another review publisher.none
product-aware
The same slot as on every card. The line came over with the card layout and was not rewritten.Template residue (a scoring system cited and never shown). The sibling page rewrote these lines to name each rival's evidence; this earlier page did not. Not checked online in this task.drop
Never cite a scoring system we do not publish. CS-P1's scores are three named axes out of ten, shown on the card.
25
49.3%
ranked-entry
2× h2 · h3 · p · 9 w
Card three: Purelia Liver Restore, from the brand of the same name, graded B+.consensus
product-aware
Third place, a third of a letter below second. The grades fall in the smallest steps the scale allows.Name, maker, letter. No summary line, so nothing is learned until the lists.keep-structure
CS-P1's rival headers carry a category line and a tagline that states the catch. Ours tell more. Already has.
26
51.1%
ranked-entry
h2 · 4× p · 31 w
Four pros: a multi-pathway formula (dandelion, artichoke and milk thistle alongside NAC, glutathione and choline), a liquid taken straight or in water, third-party testing according to the maker, and a 60-day guarantee.candor
product-aware
Pros fall from five to four with rank, as on the sibling page. The attribution on the testing claim keeps the reviewer uncommitted.An ingredient list in brackets does the praising. The template's slot counts are visible: nine, five, four, three, three.keep-structure
Already in CS-P1: three true pros per rival.
27
53.4%
ranked-entry
h2 · 5× p · 42 w
Five cons: amounts hard to verify, a dropper that travels worse than a softgel, a shorter guarantee than the winner's, a formula too complex for a one-ingredient shopper, and outcome claims on the rival's page that need careful reading.contrastloss-aversion
product-aware
Three of the five name or imply the winner. The last con questions the rival's marketing, which prepares the reader to discount anything they later read on the rival's site.The last con criticises marketing language from a page that is itself marketing. The wording is hedged enough to be safe.rewrite-claim
No guarantee-length markdown (ours is 30 days). What transfers: amounts a buyer cannot verify, against our full 12 mg stated per softgel and lab results. CS-P1 has this.
b7c3
28
56.6%
ranked-entry
h3 · p · 32 w
The verdict calls it the broadest formula of the five, tied to three functions (antioxidant defence, the flow of bile, the handling of fat), and says that breadth makes open dosing matter more.candorcontrast
product-aware
It grants the appeal and attaches a condition in the same paragraph, so the reader carries the condition into the bottom line.Two sentences, the second starting with a concession. Even-handed to the point of having no edge.keep-structure
Already the order of CS-P1's rival paragraphs: the strength, then the catch.
29
58.6%
ranked-entry
h3 · p · 41 w
The bottom line says it may suit shoppers who want a complete liquid detox, and gives three reasons for third place: a more complicated formula, a less handy dropper, and a guarantee of 60 days against 90.contrastease
product-aware
Card end. The voice shifts from the singular to the plural here, the page's one use of an editorial plural for a ranking decision.The reasons are about ease and the return window, none about whether it works.keep-structure
CS-P1's verdict tags give the reason in a phrase. Keep ours, without the guarantee comparison.
30
60.4%
disclosure
fine · 22 w
The same small print as under card two, crediting the borrowed ranking system.none
product-aware
Under the card's last line, as on every rival card. The slot is fixed by the template, so the same line lands here whether or not it fits.Repeated word for word three times on the page.drop
As for card two: never cite a scoring system we do not publish.
31
61.7%
ranked-entry
h2 · h3 · p · 7 w
Card four: Hepagard from Nutreance, the one rival that also appears on the sibling page, third there and fourth here. The grade letter is missing from the extracted rows; its neighbours are B+ and B-.consensus
product-aware
Fourth of five. The same product gets a different rank and different facts on two pages of one store, which shows the cards are written to fit each list.Header only. On the sibling page this rival is credited with a placebo-controlled study; here the study is never mentioned.keep-structure
A rival should carry the same facts on every page we publish. CS-P1's rival facts come from one dated reading of each product page; reuse those.
32
63.7%
ranked-entry
h2 · 3× p · 18 w
Three pros: a five-ingredient formula, NAC with established botanicals, and a vegan, gluten-free, non-GMO profile according to the maker.candor
product-aware
Pros fall to three. The study that was this rival's best point on the sibling page is left out, so there is less to concede.Short and flat. The first two pros say nearly the same thing.keep-structure
Already in CS-P1: three true pros per rival.
33
65.4%
ranked-entry
h2 · 5× p · 44 w
Five cons: serving guidance that runs from one to four capsules, only 30 days of guarantee, strong detox and fatty-liver wording that belongs with a clinician, a dated presentation with little standardised-dose detail, and possibly several capsules a day.contrastloss-aversionease
product-aware
The variable serving is set against the winner's single softgel, the theme of every card on this page.The first and last cons are the same point made twice. One con criticises how the rival's page looks, which is taste, not fact.rewrite-claim
Serving clarity transfers: one softgel a day against several. The guarantee point does not (ours is 30 days). CS-P1 has the serving point on the Rovina card.
b9b7
34
68.7%
ranked-entry
h3 · p · 32 w
The verdict describes a long-standing capsule product based on NAC plus four other natural ingredients, and reports the maker's statements on allergens, batch testing and a certified facility.candor
product-aware
Verdict slot. Everything is attributed to the maker, which keeps the reviewer from vouching for any of it.Two sentences of description. No judgment is made until the bottom line.keep-structure
Already in CS-P1: the strength first, stated as the brand's own claim.
35
70.5%
ranked-entry
h3 · p · 33 w
The bottom line grants that it covers the traditional bases, then gives two reasons for its rank: serving guidance less clear than the fixed servings above it, and the shortest guarantee of the five.contrastcandor
product-aware
Card end, same template as the two cards above: every rival leaves on the reason for its rank, so the last thing remembered about each is why it lost.Clear and short. Again the reasons are ease and the return window.keep-structure
As above, without the guarantee comparison. CS-P1 has the verdict tag.
36
72.3%
disclosure
fine · 22 w
The same borrowed small print, a third time.none
product-aware
The same fixed slot under the fourth card. By the third sighting, anyone who reads fine print knows the line is boilerplate.Identical to the two before it.drop
As for card two.
37
73.6%
ranked-entry
h2 · h3 · 2× p · 12 w
Card five: Snap Liver Health & Detox from Snap Supplements, graded B-. The lowest grade on this page is still a B.consensus
product-aware
Last place. With every rival graded B or better, the list reads as five good products, which makes the winner's lead look small.A flat grade range takes the drama out of a ranking. The sibling page runs from the top grade down to a C-, which reads as a verdict.keep-structure
CS-P1's scores range widely by axis (from 3.0 to 10), so differences are visible. Keep ours.
38
75.6%
ranked-entry
h2 · 3× p · 24 w
Three items under the pros heading: advertised third-party testing with a 90-day guarantee, a two-capsule serving compared with one softgel (a drawback filed as a pro), and broad positioning across detox, digestion and antioxidant support.candor
product-aware
Pros slot of the last card. The template's count of three was filled, one of them with a con.The heading is in capitals here and not on the other cards. The misfiled item shows the card was assembled without a read-through.keep-structure
Already in CS-P1. A misfiled line is a reminder to read every card in the built page, not in the config.
39
77.7%
ranked-entry
h2 · 3× p · 33 w
Three cons that fit the product: its single-bottle price is above the winner's, its green tea can disagree with some users or medicines, and its benefits are spread over several botanicals.contrastloss-aversion
product-aware
The price con compares with the winner's price, which this page never states. The focus con repeats the winner's position: one active against a blend.A price comparison with no prices. The caution about green tea is the one new fact.keep-structure
Price comparisons need the figures. CS-P1 works cost per day from each rival's own site. Already has.
40
79.7%
ranked-entry
4× p · 69 w
Four more cons describe a different product: a 30-softgel bottle, a carotenoid from the sea instead of traceable microalgae, a cost that climbs when dosing up to 12 mg, and a plain softgel sold for eyes, heart, brain and immunity.none
product-aware
No reason. Leftover rows at the end of the last card, the part of a template least likely to be proofread.A production error, and an instructive one: it shows the liver pages were cloned from the astaxanthin ranking. These four keep the label-and-reason style of the sibling page. A reader who gets this far sees a capsule blend criticised for being a softgel.drop
Nothing to take except the warning. Our builder clones a donor page too, and asserts that donor strings are gone. Every sibling page needs the same check on every card, the last one most of all.
41
82.9%
ranked-entry
h3 · p · 31 w
The verdict describes the right product: four actives (dandelion, CoQ10, green tea, standardised milk thistle) taken as two capsules a day, a familiar blend whose testing and 90-day refund window are both advertised.candor
product-aware
Verdict slot, written for this product, between two sets of leftover lines. It shows the card was partly rewritten: the middle was done and both ends were left.Accurate and flat. Surrounded by lines about another product, it reads as the odd one out.keep-structure
Already in CS-P1: a neutral description before the catch.
42
84.6%
ranked-entry
h3 · p · 55 w
The bottom line is about another brand entirely: it names Life Extension, praises a phospholipid absorption feature, calls 4 mg underdosed, and says a cheap bottle is no longer cheap once enough softgels are taken to make 12 mg.none
product-aware
No reason. The last paragraph of the last card was never rewritten.The best-written paragraph on the page, and it belongs to a card that is not here: spoken, specific, with a turn. It shows how the store marks down a low-dose astaxanthin rival: price it at the full dose.keep-structure
As a line here it is an error. As a move it is ours: price a rival at the full 12 mg, not per bottle. The gate holds 12 mg against 4 to 6 mg products. CS-P1 does this on the Rovina card and in the cost-per-day axis. Already has.
b7
43
87.1%
close
h2 · p · 31 w
A heading names the winner as the pick for everyday liver support. One sentence says that, of the five compared, it stood out for a focused formula, open dosing, a simple routine and strong buyer protection.loop-closedconsensus
product-aware
Directly after the last card. The four reasons are the four themes the rival cards were marked down on, so the recap reads as the sum of the list.One sentence with a four-item list. No number, no price. Buyer protection stands in for the guarantee.keep-structure
CS-P1 has no recap right after the fifth card; it goes to the timeline. A short one there is the change. No liver.
b7c3
44
88.6%
differentiation
4× p · 32 w
The first four ticks of a checklist: 12 mg of natural astaxanthin for antioxidant support, help for the liver's defences against oxidative stress, an oil softgel suited to a fat-soluble ingredient, and one softgel a day.specificityease
product-aware
A checklist after the recap sentence gives the skimmer the product in a glance. These four are what it is and how it is taken.Each line is a feature plus a purpose clause, all the same length. Three of the four were already in the winner's pros.rewrite-claim
No liver. Ours: the full 12 mg in one softgel, natural microalgae, The Cell Shield across the whole cell membrane, one softgel with a meal. CS-P1's proof bar has three ticks, placed after the timeline.
b7c4m2b9r31
45
90.1%
differentiation
4× p · 22 w
The last four ticks: outside testing, no hidden blend, the 90-day money-back guarantee, and a design meant for long-term use.borrowed-authorityrisk-reversalcontrast
product-aware
Trust and guarantee come after the product facts, the same order as the card. The blend line keeps the contrast with the rivals alive in the recap.The last tick repeats the first half of the list in vaguer words. Eight ticks is twice what a reader will hold.swap-offer
Ours: third-party lab tested every batch, the amount stated per softgel, the 30-Day Money-Back Guarantee, keep the bag. CS-P1 has these in the proof bar and the closing block.
c3b7
46
91.8%
mechanism
h2 · p · 47 w
A section heading promises focused, everyday protection of a liver that is overworked. The paragraph names its buyer (someone unsatisfied by a short cleanse) and repeats how the softgel supports defences against strain from diet, alcohol, medicines and metabolism.new-mechanismidentificationloop-closed
product-aware
Near the end the page returns to the image it opened with, the organ that never rests. The sources of strain are the ones named in the problem block, so the reader hears their own situation answered.The heading is the most concrete on the page. The paragraph under it repeats the winner's verdict in other words.swap-mechanism
No liver. The loop we can close is the one CS-P1's intro opens: vitamins that never reach the inside of the cell, and The Cell Shield that spans the membrane. CS-P1's final paragraph does not return to its opening. It lacks this.
m2p3r5r1
47
94.0%
future-pace
p · 30 w
One sentence gathers the routine, the testing and the guarantee into a simple long-term plan, and lists five outcomes it supports, ending on energy and a clear head.future-pacingeaserisk-reversal
product-aware
After the working principle, the habit. It is the last persuasive sentence before the link, so it ends on how the reader hopes to feel.A five-item list of outcomes, each an abstraction. The two that a person can feel come last, which is the right order.rewrite-claim
No liver. The outcomes the gate holds with a time frame: steadier energy in weeks one to two, a clearer head, less eye strain in two to four weeks. CS-P1 has a full week-by-week timeline, which is stronger than a list. Already has.
r7r6b6r24
48
95.1%
cta
p · 5 w
The second link out, at 95%: the same soft text link.commitmentease
product-aware
Nearly 60% of the page lies between the first link and this one.Identical wording. Still no price.keep-structure
CS-P1's sticky bar and sidebar keep a link in reach throughout. Already stronger.
49
95.8%
close
h2 · p · 39 w
A final section on why it ranked first: one sentence lists six strengths, from cell protection and the stated 12 mg dose to convenience and buyer protection, and ends by setting it against products that hide behind a long blend.contrastloop-closedcommon-enemy
product-aware
The last prose on the page. It ends on the villain, the hidden blend, so the final contrast is fresh when the last link appears.Thirty-five words, a six-item list and a long dash. The closing jab is the only phrase with an edge.keep-structure
CS-P1's closing paragraph is three facts and one line. Shorter and better for our reader. Keep ours. No liver.
b7c3
50
97.8%
cta
p · 7 w
The last link, at 98%: a trial of ninety days at no risk, the only hard ask on the page.risk-reversalcommitment
product-aware
With no price anywhere, the guarantee is the whole offer at the point of the click.Same seven words as the sibling page.swap-offer
Our button offers a risk-free trial of The Cell Shield with the 30-day money-back line and the price beside it. CS-P1 has it.
51
99.6%
page-furniture
fine · 8 w
The same copyright line as the sibling page, naming a health news title as publisher.none
product-aware
Last line of the page, after the final link. It is the only place a publisher is named, so a reader who wonders who wrote the ranking learns it only after deciding.Shared furniture. The publisher's name does not match the store's domain.page-furniture
CS-P1 has a full footer under its own review title.